Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Corgenix teams up with SpectraCell for AspirinWorks

This article was originally published in Clinica

Executive Summary

Denver, Colorado-based IVD company Corgenix has formed a partnership with Houston, Texas lab testing services firm SpectraCell, which will see the latter use Corgenix's AspirinWorks test to assess a patient's risk of an adverse cardiovascular event. AspirinWorks determines the effect of aspirin on platelets in apparently healthy individuals by measuring the level of thromboxane production (the higher the levels of thromboxane, the sticker the blood platelets and the increased likelihood of a blood clot-related cardiovascular event).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042455

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel